It is absolutely nowhere close to normal. And is actually longer than abnormal.
I know the company line is that this takes longer because it is “paradigm shifting”. That may be true. But while this may be a paradigm shifting technology, it is by no means the first paradigm shifting technology in biotech. Others have happened, and the process did not take this long.
Linda Powers simply has no idea what she’s doing. Or she knows exactly what she is doing. Which is lining her own pockets with shareholder money.
It’s painfully obvious that Linda wanted NWBO to simply be a special purpose vehicle for their own benefit.
You realize Linda has been mainly paid in shares and options. Shares which she still holds. The same shares retail holds. Management will profit, as will retail, when NWBO succeeds. This repeated narrative is nonsense.
Congratulations on your long position once again! Your post is full of falsehoods in my view. LP is a shareholder too. Years ago, she loaned her own money to fund clinical research into DCVax-L.